Timing and management of bleeding after bariatric surgery.


Journal

Surgical endoscopy
ISSN: 1432-2218
Titre abrégé: Surg Endosc
Pays: Germany
ID NLM: 8806653

Informations de publication

Date de publication:
10 2023
Historique:
received: 20 02 2023
accepted: 11 06 2023
medline: 27 9 2023
pubmed: 4 7 2023
entrez: 3 7 2023
Statut: ppublish

Résumé

The timing of bleeding after bariatric surgery and subsequent management (characterized as surgical versus non-surgical (i.e., interventions including endoscopic or interventional radiology approaches)) has not been thoroughly studied. As such, we sought to describe the rates of reoperation or non-operative intervention after bleeding following sleeve gastrectomy (SG) or Roux-en-Y gastric bypass (RYGB). The Metabolic and Bariatric Accreditation and Quality Improvement Program (MBSAQIP) database was queried between 2015 and 2018 for any bleeding after SG or RYGB and subsequent reoperation or non-operative intervention. Multivariable Fine-Gray models were used to compare the hazard of reoperation/non-operative intervention. Multivariable generalized linear regression models were used to test the number of subsequent reoperations/non-operative interventions depending on initial management. 6251 patients with bleeding after SG or RYGB were identified, of which 2653 patients underwent subsequent procedures (n = 1375 [51.83%] RYGB index procedure, n = 1278 [48.17%] SG index procedure). 1892 (71.32%) and 761 (28.68%) patients had reoperation and non-operative intervention, respectively. For patients who developed bleeding, SG was associated with significantly higher reoperation risk, while RYGB was associated with significantly higher risk of non-operative intervention. Early bleeding was associated with significantly increased risk of reoperation and decreased risk of non-operative intervention, regardless of initial procedure. The total number of subsequent reoperations/non-operative interventions did not differ significantly depending on whether the patients had non-operative intervention or reoperation first [ratio 1.01, 95% CI (0.75, 1.36), p value 0.9418]. Patients after SG who experience bleeding are more likely to undergo reoperation than RYGB patients. On the other hand, patients with bleeding after RYGB are more likely to undergo non-operative intervention compared to SG patients. Early bleeding is associated with higher risk of reoperation and lower risk of non-operative intervention both after SG and RYGB. The initial approach did not play a role in the total number of subsequent reoperations/non-operative interventions.

Sections du résumé

BACKGROUND
The timing of bleeding after bariatric surgery and subsequent management (characterized as surgical versus non-surgical (i.e., interventions including endoscopic or interventional radiology approaches)) has not been thoroughly studied. As such, we sought to describe the rates of reoperation or non-operative intervention after bleeding following sleeve gastrectomy (SG) or Roux-en-Y gastric bypass (RYGB).
METHODS
The Metabolic and Bariatric Accreditation and Quality Improvement Program (MBSAQIP) database was queried between 2015 and 2018 for any bleeding after SG or RYGB and subsequent reoperation or non-operative intervention. Multivariable Fine-Gray models were used to compare the hazard of reoperation/non-operative intervention. Multivariable generalized linear regression models were used to test the number of subsequent reoperations/non-operative interventions depending on initial management.
RESULTS
6251 patients with bleeding after SG or RYGB were identified, of which 2653 patients underwent subsequent procedures (n = 1375 [51.83%] RYGB index procedure, n = 1278 [48.17%] SG index procedure). 1892 (71.32%) and 761 (28.68%) patients had reoperation and non-operative intervention, respectively. For patients who developed bleeding, SG was associated with significantly higher reoperation risk, while RYGB was associated with significantly higher risk of non-operative intervention. Early bleeding was associated with significantly increased risk of reoperation and decreased risk of non-operative intervention, regardless of initial procedure. The total number of subsequent reoperations/non-operative interventions did not differ significantly depending on whether the patients had non-operative intervention or reoperation first [ratio 1.01, 95% CI (0.75, 1.36), p value 0.9418].
CONCLUSION
Patients after SG who experience bleeding are more likely to undergo reoperation than RYGB patients. On the other hand, patients with bleeding after RYGB are more likely to undergo non-operative intervention compared to SG patients. Early bleeding is associated with higher risk of reoperation and lower risk of non-operative intervention both after SG and RYGB. The initial approach did not play a role in the total number of subsequent reoperations/non-operative interventions.

Identifiants

pubmed: 37400686
doi: 10.1007/s00464-023-10201-y
pii: 10.1007/s00464-023-10201-y
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

7437-7443

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Dick A, Byrne TK, Baker M, Budak A, Morgan K (2010) Gastrointestinal bleeding after gastric bypass surgery: nuisance or catastrophe? Surg Obes Relat Dis 6(6):643–647. https://doi.org/10.1016/j.soard.2010.07.016
doi: 10.1016/j.soard.2010.07.016 pubmed: 21111381
Bakhos C, Alkhoury F, Kyriakides T, Reinhold R, Nadzam G (2009) Early postoperative hemorrhage after open and laparoscopic Roux-en-Y gastric bypass. Obes Surg 19(2):153–157. https://doi.org/10.1007/s11695-008-9580-1
doi: 10.1007/s11695-008-9580-1 pubmed: 18629595
Mehran A, Szomstein S, Zundel N, Rosenthal R (2003) Management of acute bleeding after laparoscopic Roux-en-Y gastric bypass. Obes Surg 13(6):842–847. https://doi.org/10.1381/096089203322618623
doi: 10.1381/096089203322618623 pubmed: 14738667
Augustin T, Aminian A, Romero-Talamás H, Rogula T, Schauer PR, Brethauer SA (2016) Reoperative surgery for management of early complications after gastric bypass. Obes Surg 26(2):345–349. https://doi.org/10.1007/s11695-015-1767-7
doi: 10.1007/s11695-015-1767-7 pubmed: 26140855
Giannopoulos S, Pokala B, Stefanidis D (2022) Management of gastrointestinal bleeding following bariatric surgery. Mini-invasive Surg 6:22
doi: 10.20517/2574-1225.2021.135
Yong S et al (2019) Post-operative bleeding complications in laparoscopic sleeve gastrectomy: sources, solutions and lessons learnt from a single cohort of patients. Hypertension 170:41–46
Jossart GH (2010) Complications of sleeve gastrectomy: bleeding and prevention. Surg Laparosc Endosc Percutan Tech 20:146–147
doi: 10.1097/SLE.0b013e3181e3558b pubmed: 20551810
Heneghan HM, Meron-Eldar S, Yenumula P, Rogula T, Brethauer SA, Schauer PR (2012) Incidence and management of bleeding complications after gastric bypass surgery in the morbidly obese. Surg Obes Relat Dis 8(6):729–735. https://doi.org/10.1016/j.soard.2011.05.011
doi: 10.1016/j.soard.2011.05.011 pubmed: 21798818
Jensen C, Mehran A, Lewis C (2008) Acute bleeding after gastric bypass. Bariatric Times. June 11, 2008. https://bariatrictimes.com/acute-bleeding-after-gastric-bypass/
Klaassen RA, Selles CA, van den Berg JW, Poelman MM, van der Harst E (2018) Tranexamic acid therapy for postoperative bleeding after bariatric surgery. BMC Obes 5:36. https://doi.org/10.1186/s40608-018-0213-5
doi: 10.1186/s40608-018-0213-5 pubmed: 30524741 pmcid: 6276262
Nguyen N, Rivers R, Wolf B (2003) Early gastrointestinal hemorrhage after laparoscopic gastric bypass. Obes Surg 13(1):62–65
doi: 10.1381/096089203321136601 pubmed: 12630615
Aiolfi A, Gagner M, Zappa MA et al (2022) Staple line reinforcement during laparoscopic sleeve gastrectomy: systematic review and network meta-analysis of randomized controlled trials. Obes Surg 32:1466–1478. https://doi.org/10.1007/s11695-022-05950-z
doi: 10.1007/s11695-022-05950-z pubmed: 35169954 pmcid: 8986671
Sroka G, Milevski D, Shteinberg D, Mady H, Matter I (2015) Minimizing hemorrhagic complications in laparoscopic sleeve gastrectomy—a randomized controlled trial. Obes Surg 25(9):1577–1583. https://doi.org/10.1007/s11695-015-1580-3
doi: 10.1007/s11695-015-1580-3 pubmed: 25596939
Boules M, Chang J, Haskins IN, Sharma G, Froylich D, El-Hayek K, Rodriguez J, Kroh M (2016) Endoscopic management of post-bariatric surgery complications. World J Gastrointest Endosc 8(17):591–599
doi: 10.4253/wjge.v8.i17.591 pubmed: 27668069 pmcid: 5027029
Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) (2021) User guide for the 2020 participant use data file (PUF). https://www.facs.org/media/1d2dlnma/mbsaqip_puf_userguide_2020.pdf . Accessed 20 June 2022.

Auteurs

Zaina Naeem (Z)

Department of Surgery, Renaissance School of Medicine, Stony Brook, NY, USA.

Panagiotis Volteas (P)

Department of Surgery, Renaissance School of Medicine, Stony Brook, NY, USA.

Alisa Khomutova (A)

Department of Surgery, Renaissance School of Medicine, Stony Brook, NY, USA.

Abeer Naeem (A)

New York Institute of Technology College of Osteopathic Medicine, Old Westbury, NY, USA.

Jie Yang (J)

Department of Family, Population and Preventive Medicine, Renaissance School of Medicine, Stony Brook, NY, USA.

Lizhou Nie (L)

Department of Applied Mathematics and Statistics, Stony Brook University, Stony Brook, NY, USA.

Omar M Ghanem (OM)

Department of Surgery, Mayo Clinic, Rochester, MN, USA.

Konstantinos Spaniolas (K)

Department of Surgery, Renaissance School of Medicine, Stony Brook, NY, USA.
Division of Bariatric, Foregut, and Advanced Gastrointestinal Surgery, Department of Surgery, Renaissance School of Medicine, Stony Brook, NY, USA.

Panagiotis Drakos (P)

Highland Hospital, Rochester University, 1000 South Avenue, Rochester, NY, 14620, USA. Panagiotis_Drakos@URMC.Rochester.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH